Understanding the scope for innovations in vaccine technology in the swine industry
Pig production is a vital component of the Canadian agricultural sector. Airborne bacterial pathogens Haemophilus parasuis, Actinobacillus pleuropneumoniae and Actinobacillus suis are major causes of swine respiratory disease and cause rapidly progressing systemic infections that lead to significant morbidity and mortality. We are developing engineered subunit vaccines that can simultaneously target all three pathogens and can be formulated for needle-free delivery using pressure guns. This project will examine the current pig vaccine landscape against these disease-causing bacteria and determine the need, feasibility and acceptability for innovative vaccine products with improved efficacy. The research outcomes will have a significant impact on the commercialization decisions made by our business partner.